Buy Generic Enclomiphene Online
|
|
Generic Enclomiphene 50mg
Package | Price | Per Pill | Shipping | Order | |
50mg x 30 pills | $52.02 | $1.73 | Add to Cart | ||
50mg x 60 pills | $68.96 | $1.15 | Add to Cart | ||
50mg x 90 pills | $89.21 | $0.99 | Add to Cart | ||
50mg x 120 pills | $98.70 | $0.82 | Add to Cart | ||
50mg x 180 pills | $134.77 | $0.74 | Add to Cart |
Generic Enclomiphene Information
Introduction
Enclomiphene is a selective estrogen receptor modulator (SERM) developed for the treatment of male hypogonadism and associated low‑testosterone states. The active compound, Enclomiphene, belongs to the Men’s Health medication group and is increasingly discussed in the United Kingdom for its ability to stimulate endogenous testosterone production without the need for exogenous hormone replacement. While the drug is not yet listed on the UK National Health Service formulary, clinical evidence from Phase II and III trials supports its use in adult men with secondary hypogonadism.
What is Enclomiphene?
Enclomiphine is the generic version of the original investigational product Enclomiphene citrate, originally developed by Repros Therapeutics. It contains the same active compound, Enclomiphene, and is marketed internationally under the brand name Enclomiphene. Our online pharmacy provides this generic alternative as a cost‑effective treatment option.
- Classification: Selective estrogen receptor modulator (SERM)
- Development: First synthesized as one of the two geometric isomers of clomiphene; the trans‑isomer (Enclomiphene) retains the testosterone‑stimulating activity while minimizing anti‑estrogenic effects on the endometrium.
- Manufacturer (where disclosed): Repros Therapeutics (original developer); generic supplies are sourced from GMP‑certified overseas manufacturers.
How Enclomiphene Works
Enclomiphene binds competitively to estrogen receptors in the hypothalamus. By antagonising these receptors, the drug reduces negative feedback of circulating estrogen on the hypothalamic‑pituitary axis. The resulting increase in gonadotropin‑releasing hormone (GnRH) secretion elevates luteinising hormone (LH) and follicle‑stimulating hormone (FSH) release from the pituitary.
- Therapeutic effect: Elevated LH and FSH stimulate Leydig cells in the testes, leading to an increase in endogenous testosterone production.
- Onset and duration: Serum testosterone typically rises within 5–7 days of initiating therapy; steady‑state levels are achieved after 2–3 weeks. The plasma half‑life of Enclomiphene is approximately 10–12 hours, allowing once‑daily dosing.
- Clearance: Primarily hepatic metabolism via CYP3A4; metabolites are excreted renally.
Conditions Treated with Enclomiphene
- Secondary (hypogonadotropic) male hypogonadism – characterized by low testosterone due to impaired hypothalamic‑pituitary signaling. In the UK, an estimated 2‑5 % of adult men meet biochemical criteria for hypogonadism, with a substantial proportion having a secondary etiology. Enclomiphene restores physiological testosterone levels while preserving fertility.
- Infertility linked to low gonadotropins – by raising LH and FSH, the drug can improve spermatogenesis in men with oligo‑zoospermia secondary to hypogonadotropic dysfunction.
- Potential off‑label use for age‑related testosterone decline – some clinicians consider Enclomiphene for men with symptomatic low testosterone who prefer a non‑exogenous approach; however, this indication remains investigational in the UK.
Who is Enclomiphene For?
Enclomiphene is appropriate for adult men (≥18 years) who:
- Have documented low‑testosterone (<300 ng/dL) with concomitant low or inappropriately normal LH/FSH, indicating secondary hypogonadism.
- Desire to maintain fertility; the drug stimulates endogenous testosterone without suppressing spermatogenesis.
- Prefer to avoid long‑term exogenous testosterone therapy, which may require injections or transdermal gels.
Contra‑indications – Enclomiphene should not be used in:
- Women who are pregnant, lactating, or of child‑bearing potential without appropriate contraception (due to teratogenic risk).
- Men with known estrogen‑dependent cancers (e.g., breast, endometrial).
- Individuals with uncontrolled hepatic disease or severe renal impairment, as metabolism and excretion may be altered.
Risks, Side Effects, and Interactions
Common adverse events
- Hot flashes – reported in up to 15 % of users; usually mild and transient.
- Headache – frequency similar to placebo in clinical trials.
- Gastrointestinal upset – mild nausea or abdominal discomfort occasionally observed.
Rare adverse events
- Visual disturbances – rare reports of blurred vision; patients should report new ocular symptoms promptly.
- Mood changes – occasional irritability or mild depression; monitor mental health status.
Serious adverse events
- Thromboembolic events – isolated cases of deep‑vein thrombosis; risk may be heightened in patients with pre‑existing clotting disorders.
- Hepatotoxicity – very rare elevations in liver enzymes; discontinue if transaminases rise >3 × ULN.
Drug–drug interactions
- CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) may increase Enclomiphene plasma levels, potentially augmenting side‑effects.
- CYP3A4 inducers (e.g., rifampicin, carbamazepine) may reduce efficacy by accelerating metabolism.
- Warfarin – Enclomiphene may potentiate anticoagulant effects; INR monitoring recommended.
Practical Use: Dosing, Missed Dose, Overdose
- Standard dosing: 12.5 mg to 25 mg oral tablet taken once daily in the morning with food to improve absorption. Dose titration is guided by serum testosterone levels and clinical response.
- Missed dose: If a dose is forgotten, take it as soon as remembered unless it is close to the next scheduled dose; do not double‑dose.
- Overdose: In the event of accidental ingestion of more than 2 × the prescribed dose, seek medical attention. Management is supportive, focusing on symptom monitoring (e.g., severe headache or visual changes).
- Precautions: Avoid excessive alcohol, which can exacerbate hepatotoxic risk. Carry a list of current medications to inform healthcare providers of potential interactions.
Buying Enclomiphene from Our Online Pharmacy
Enclomiphene can be purchased from our online pharmacy in the UK. Our service offers:
- Affordable pricing – generic Enclomiphene is supplied at a cost close to manufacturer wholesale rates, reducing the financial burden for patients.
- Verified quality – all tablets are sourced from GMP‑certified overseas suppliers and undergo independent testing before dispatch.
- Guaranteed delivery – discreet packaging with express shipping (typically 7 days) or regular airmail (≈3 weeks).
- Online‑only access – we act as a pharmacy‑broker service, partnering with licensed international pharmacies to provide medications not readily available through UK NHS channels. Our discreet service respects patient privacy while ensuring compliance with UK import regulations.
FAQ
-
Is Enclomiphene available in both brand‑name and generic forms in the UK?
Yes. The original investigational product was marketed under the brand name Enclomiphene citrate, while generic versions containing the same active compound are now accessible through reputable online pharmacies. -
Does Enclomiphene require cold storage?
No. Enclomiphene tablets should be stored at controlled room temperature (15‑25 °C), away from direct sunlight, moisture, and heat sources. -
What does the packaging of Enclomiphene look like when ordered online?
Tablets are supplied in a sealed, tamper‑evident blister pack or a high‑density polymer bottle, each bearing a batch number, expiry date, and clear label indicating the active strength. -
Can Enclomiphene be safely imported into the UK for personal use?
Personal import of a three‑month supply of a licensed medication for personal use is permitted under UK law, provided the product is sourced from a licensed overseas pharmacy and documented appropriately. -
Are there specific warnings for Enclomiphene in patients of Asian ancestry?
Clinical studies have not identified ethnicity‑specific safety concerns; however, providers may monitor liver function more closely in populations with a higher prevalence of hepatic enzyme polymorphisms. -
Does Enclomiphene differ in formulation between the US, EU, and Asian markets?
The active ingredient is identical, but excipient compositions may vary slightly to meet regional pharmacopeial standards. Such differences do not typically affect clinical efficacy. -
What is the expected timeline for testosterone increase after starting Enclomiphene?
Most men experience a measurable rise in serum testosterone within one week, with plateau levels generally reached after three weeks of consistent dosing. -
Is it necessary to have a blood test before beginning Enclomiphene therapy?
Baseline assessment of testosterone, LH, FSH, liver enzymes, and renal function is recommended to confirm the diagnosis of secondary hypogonadism and to identify contraindications. -
Can Enclomiphene be taken with food or must it be taken on an empty stomach?
Taking the tablet with a light meal improves absorption and reduces gastrointestinal irritation; a high‑fat meal is not required. -
Will Enclomiphene affect urine drug testing for athletes?
As a SERM, Enclomiphene can be detected as a prohibited substance under certain anti‑doping regulations; athletes should consult their sport’s governing body before use.
Glossary
- Selective Estrogen Receptor Modulator (SERM)
- A class of compounds that bind to estrogen receptors and act as antagonists in some tissues (e.g., hypothalamus) while acting as agonists in others (e.g., bone).
- Gonadotropin‑releasing Hormone (GnRH)
- A decapeptide hormone released from the hypothalamus that stimulates the pituitary gland to secrete luteinising hormone (LH) and follicle‑stimulating hormone (FSH).
- Secondary (hypogonadotropic) hypogonadism
- A condition in which low testosterone results from inadequate signaling from the hypothalamus or pituitary, rather than a primary testicular defect.
- Bioavailability
- The proportion of an administered dose of medication that reaches systemic circulation in an active form.
⚠️ Disclaimer
The information provided about Enclomiphene is for general knowledge only. It does not replace professional medical consultation. All treatment decisions should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to Enclomiphene for individuals who may have limited availability through traditional pharmacies, prescription‑based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.